MARRONE BIO INNOVATIONS INC's ticker is MBII and the CUSIP is 57165B106.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $125,000 | -17.8% | 107,649 | -23.7% | 0.00% | – |
Q1 2022 | $152,000 | -43.9% | 141,040 | -62.7% | 0.00% | – |
Q4 2021 | $271,000 | -46.5% | 377,790 | -32.9% | 0.00% | – |
Q3 2021 | $507,000 | -31.5% | 563,040 | +26.2% | 0.00% | – |
Q2 2021 | $740,000 | +34.8% | 446,013 | +69.9% | 0.00% | – |
Q1 2021 | $549,000 | +719.4% | 262,495 | +391.8% | 0.00% | – |
Q4 2020 | $67,000 | +294.1% | 53,378 | +278.8% | 0.00% | – |
Q3 2020 | $17,000 | -50.0% | 14,092 | -52.4% | 0.00% | – |
Q2 2020 | $34,000 | +240.0% | 29,606 | +131.1% | 0.00% | – |
Q1 2020 | $10,000 | -87.7% | 12,813 | -84.2% | 0.00% | – |
Q4 2019 | $81,000 | +118.9% | 81,044 | +214.3% | 0.00% | – |
Q3 2019 | $37,000 | +208.3% | 25,785 | +219.0% | 0.00% | – |
Q2 2019 | $12,000 | -57.1% | 8,084 | -56.8% | 0.00% | – |
Q1 2019 | $28,000 | -83.7% | 18,695 | -84.0% | 0.00% | – |
Q4 2018 | $172,000 | -27.1% | 117,073 | -9.2% | 0.00% | – |
Q3 2018 | $236,000 | +9.8% | 128,917 | +10.3% | 0.00% | – |
Q2 2018 | $215,000 | +21400.0% | 116,907 | +24255.6% | 0.00% | – |
Q1 2018 | $1,000 | 0.0% | 480 | 0.0% | 0.00% | – |
Q4 2017 | $1,000 | 0.0% | 480 | 0.0% | 0.00% | – |
Q3 2017 | $1,000 | 0.0% | 480 | -7.7% | 0.00% | – |
Q2 2017 | $1,000 | -50.0% | 520 | -45.8% | 0.00% | – |
Q1 2017 | $2,000 | 0.0% | 960 | 0.0% | 0.00% | – |
Q4 2016 | $2,000 | +100.0% | 960 | +100.0% | 0.00% | – |
Q3 2016 | $1,000 | – | 480 | 0.0% | 0.00% | – |
Q2 2016 | $0 | -100.0% | 480 | -75.2% | 0.00% | – |
Q1 2016 | $1,000 | -90.0% | 1,936 | -78.8% | 0.00% | – |
Q4 2015 | $10,000 | -88.6% | 9,151 | -78.3% | 0.00% | – |
Q3 2015 | $88,000 | +4.8% | 42,076 | -1.2% | 0.00% | – |
Q2 2015 | $84,000 | +320.0% | 42,584 | +704.8% | 0.00% | – |
Q1 2015 | $20,000 | -75.6% | 5,291 | -76.5% | 0.00% | – |
Q4 2014 | $82,000 | +12.3% | 22,512 | -17.9% | 0.00% | – |
Q3 2014 | $73,000 | -82.8% | 27,415 | -24.9% | 0.00% | – |
Q2 2014 | $425,000 | -15.5% | 36,509 | +1.5% | 0.00% | – |
Q1 2014 | $503,000 | +16666.7% | 35,984 | +24378.9% | 0.00% | – |
Q4 2013 | $3,000 | -99.3% | 147 | -99.4% | 0.00% | – |
Q3 2013 | $405,000 | – | 24,063 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARDSLEY ADVISORY PARTNERS LP | 14,303,099 | $15,635,000 | 3.02% |
ICM ASSET MANAGEMENT INC/WA | 21,500 | $26,000 | 0.14% |
Fairpointe Capital LLC | 613,900 | $749,000 | 0.12% |
WADDELL & REED FINANCIAL INC | 25,095,634 | $30,617,000 | 0.07% |
WEDBUSH SECURITIES INC | 37,129 | $45,000 | 0.00% |
Financial Advocates Investment Management | 30,925 | $38,000 | 0.00% |
PRIMECAP MANAGEMENT CO/CA/ | 2,035,300 | $2,483,000 | 0.00% |
Avior Wealth Management, LLC | 10,000 | $12,000 | 0.00% |
AMALGAMATED BANK | 10,217 | $12,000 | 0.00% |
Tower Research Capital LLC (TRC) | 73,897 | $90,000 | 0.00% |